Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Multiple Sclerosis
NCT01490502Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Mar 2012
- Primary completion
- May 2021
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d in relapsing-remitting multiple sclerosis (RRMS), sponsored by Johns Hopkins University. Started Mar 2012; status: completed.
02
Drugs
vitamin d
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01490502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490502.